Keryx Biopharmaceuticals Inc
KERX
KERX was delisted on the 12th of December, 2018.
128 hedge funds and large institutions have $369M invested in Keryx Biopharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 32 closing their positions.
18% more capital invested
Capital invested by funds: $313M → $369M (+$56.4M)
7% less funds holding
Funds holding: 138 → 128 (-10)
16% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 43
17.12% less ownership
Funds ownership: 86.23% → 69.11% (-17%)
31% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 32
38% less call options, than puts
Call options by funds: $4.4M | Put options by funds: $7.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.25M |
| 2 |
Millennium Management
New York
|
+$4.28M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$4.13M |
| 4 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
+$2.38M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$2.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$20.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$13.6M |
| 3 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$11.1M |
| 4 |
ACM
Apex Capital Management
Dayton,
Ohio
|
-$5.97M |
| 5 |
JP Morgan Chase
New York
|
-$5.88M |
KERX Hedge Fund Activity: Q4 2015 in Review
128 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q4 2015, worth a combined $369M — up 18% from $313M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of KERX and 22 opened new positions — a net loss of 10 holders — while 43 trimmed existing stakes and 36 added.
The largest buyer was Ameriprise, adding an estimated $7.25M. The largest seller was Franklin Resources, cutting an estimated $20.1M.
- 128 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q4 2015, down from 138 in Q3 2015.
- Funds reported $369M of Keryx Biopharmaceuticals Inc stock for Q4 2015, up 18% quarter-over-quarter.
- 22 funds opened new Keryx Biopharmaceuticals Inc positions in Q4 2015 and 32 closed out, a net change of -10 holders.
- The largest Keryx Biopharmaceuticals Inc buyer in Q4 2015 was Ameriprise, an estimated $7.25M added.
- The largest Keryx Biopharmaceuticals Inc seller in Q4 2015 was Franklin Resources, an estimated $20.1M sold.
Based on aggregated 13F filings for Q4 2015.